胺β和α-Synuclein通过激光清除和氧抑制降低金属催化反应性氧物种的水平
Jeppe T Pedersen, Serene W Chen1, Christian B Borg2
1Department of Chemistry, University of Cambridge , Lensfield Road, Cambridge CB2 1EW, United Kingdom.
Journal of the American Chemical Society
|March 12, 2016
概括
通过与铜结合的粉样β (Aβ) 和α-synuclein (αS) 来减少反应性氧物种 (ROS) 的形成. 这表明聚合不会直接增加ROS,但可能会集中金属离子,影响神经退行性疾病的途径.
科学领域:
- 生物化学
- 神经科学
- 氧化应激研究
背景情况:
- 反应性氧物种 (ROS) 与神经退行性疾病的发病有关.
- 阿尔茨海默氏症和帕金森病分别与粉样β (Aβ) 和αS蛋白聚合有关.
- 铜 (Cu2+) 等金属离子在这些疾病中产生ROS的作用正在研究中.
研究的目的:
- 在体外研究可溶和聚合的Aβ和αS对Cu(2+) 催化ROS形成的影响.
- 阐明这些在生物减少剂的存在下影响ROS生成的机制.
主要方法:
- 使用Cu2+) 催化反应的体外研究.
- 评估ROS水平和发电速度
- 使用可溶和聚合形式的粉样β (Aβ) 和α-synuclein (αS).
主要成果:
- 2+) 与Aβ和αS的结合显著降低了ROS水平和生成率.
- 和αS的寡合和纤维形式在减少ROS方面特别有效.
- 提出的机制包括金属复合体的激素清除和氧化还原沉默.
结论:
- 聚合的Aβ和αS似乎没有直接的ROS活性.
- 在神经退行性疾病中观察到的ROS增加可能来自聚合物内的局部金属离子积累.
- 粉样结构的形成可能间接导致氧化应激增加作为下游效应.
相关概念视频
Electron Transport Chain: Complex I and II
19.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Amyloid Fibrils
12.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.9K
Drugs Affecting Neurotransmitter Synthesis
2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K


